bpc-157 administration subcutaneous near injury Peptide Therapy BPC-157 for Hip Injuries: Canadian
Description
Molecular signaling pathways
The forums say 1 mL
For the frontalis muscle, injections were administered 1.5 cm above the eyebrow using a 2-line parallel, staggered distribution method with 8 subcutaneous injection sites, delivering 2 U (concentration: 40 U/mL) at each site with a 29 G needle
Humidity is the enemy of these tablets, so bathroom storage is not recommended
